BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23918305)

  • 21. Transforming growth factor-beta (TGF- 1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression.
    Kennard S; Liu H; Lilly B
    J Biol Chem; 2008 Jan; 283(3):1324-1333. PubMed ID: 17981798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.
    Bondi CD; Manickam N; Lee DY; Block K; Gorin Y; Abboud HE; Barnes JL
    J Am Soc Nephrol; 2010 Jan; 21(1):93-102. PubMed ID: 19926889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-β1 and α-smooth muscle actin in stromal fibroblasts are associated with a poor prognosis in patients with clinical stage I-IIIA nonsmall cell lung cancer after curative resection.
    Chen Y; Zou L; Zhang Y; Chen Y; Xing P; Yang W; Li F; Ji X; Liu F; Lu X
    Tumour Biol; 2014 Jul; 35(7):6707-13. PubMed ID: 24711139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
    Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF-β in thyroid cancer cells.
    Liu Z; Yang Y; Zhang Y; Ye X; Wang L; Xu G
    Oncol Rep; 2014 Jan; 31(1):153-60. PubMed ID: 24190591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway.
    Zhang L; Cheng X; Gao Y; Zhang C; Bao J; Guan H; Yu H; Lu R; Xu Q; Sun Y
    Exp Cell Res; 2016 Feb; 341(2):157-65. PubMed ID: 26826337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KSR1 is coordinately regulated with Notch signaling and oxidative phosphorylation in thyroid cancer.
    Lee J; Seol MY; Jeong S; Kwon HJ; Lee CR; Ku CR; Kang SW; Jeong JJ; Shin DY; Nam KH; Lee EJ; Chung WY; Jo YS
    J Mol Endocrinol; 2015 Apr; 54(2):115-24. PubMed ID: 25608512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
    Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
    BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
    Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
    Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 31. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference with TGF-beta1 and -beta3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma.
    Lammerts E; Roswall P; Sundberg C; Gotwals PJ; Koteliansky VE; Reed RK; Heldin NE; Rubin K
    Int J Cancer; 2002 Dec; 102(5):453-62. PubMed ID: 12432546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased type 3 deiodinase expression in papillary thyroid carcinoma.
    Romitti M; Wajner SM; Zennig N; Goemann IM; Bueno AL; Meyer EL; Maia AL
    Thyroid; 2012 Sep; 22(9):897-904. PubMed ID: 22823995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-derived growth factor receptor-α promotes lymphatic metastases in papillary thyroid cancer.
    Zhang J; Wang P; Dykstra M; Gelebart P; Williams D; Ingham R; Adewuyi EE; Lai R; McMullen T
    J Pathol; 2012 Oct; 228(2):241-50. PubMed ID: 22744707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine A promotes cell proliferation, collagen and α-smooth muscle actin expressions in rat gingival fibroblasts by Smad3 activation and miR-29b suppression.
    Chen J; Yang F; Yu X; Yu Y; Gong Y
    J Periodontal Res; 2016 Dec; 51(6):735-747. PubMed ID: 26738448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KGF-1 accelerates wound contraction through the TGF-β1/Smad signaling pathway in a double-paracrine manner.
    Peng Y; Wu S; Tang Q; Li S; Peng C
    J Biol Chem; 2019 May; 294(21):8361-8370. PubMed ID: 30894415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of endocrine gland-derived vascular endothelial growth factor in papillary thyroid cancers displaying infiltrative patterns, lymph node metastases, and BRAF mutation.
    Pasquali D; Santoro A; Bufo P; Conzo G; Deery WJ; Renzullo A; Accardo G; Sacco V; Bellastella A; Pannone G
    Thyroid; 2011 Apr; 21(4):391-9. PubMed ID: 21385081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-β pathway.
    Ma B; Xu Y; Gao H; Yang Y; Pan Y; You C
    Med Oncol; 2024 May; 41(6):137. PubMed ID: 38705933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.
    Liu J; Zhao B; Zhu H; Pan Q; Cai M; Bai X; Li X; Hu X; Zhang M; Shi J; Zheng Z; Yang A; Hu D
    Cell Tissue Res; 2020 Mar; 379(3):537-548. PubMed ID: 31776823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma.
    Zhang T; Liang L; Liu X; Wu JN; Chen J; Su K; Zheng Q; Huang H; Liao GQ
    J Oral Pathol Med; 2016 Aug; 45(7):486-93. PubMed ID: 26764364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.